Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance

被引:139
作者
Cascioferro, Stella [1 ]
Parrino, Barbara [1 ]
Carbone, Daniela [1 ]
Schillaci, Domenico [1 ]
Giovannetti, Elisa [2 ,3 ]
Cirrincione, Girolamo [1 ]
Diana, Patrizia [1 ]
机构
[1] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut S, I-90123 Palermo, Italy
[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
[3] Fdn Pisana Sci, Canc Pharmacol Lab, I-56017 Pisa, Italy
关键词
ANTI-BIOFILM ACTIVITY; INTERFERENCE COMPOUNDS PAINS; MARINE NATURAL-PRODUCTS; IN-VITRO EVALUATION; DNA GYRASE; BIOLOGICAL EVALUATION; ANTIMICROBIAL ACTIVITY; ASSAY INTERFERENCE; 4-THIAZOLIDINONE DERIVATIVES; SIDEROPHORE CEPHALOSPORIN;
D O I
10.1021/acs.jmedchem.9b01245
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thiazoles, their benzofused systems, and thiazolidinone derivatives are widely recognized as nuclei of great value for obtaining molecules with various biological activities, including analgesic, anti-inflammatory, anti-HIV, antidiabetic, antitumor, and antimicrobial. In particular, in the past decade, many compounds bearing these heterocycles have been studied for their promising antibacterial properties due to their action on different microbial targets. Here we assess the recent development of this class of compounds to address mechanisms underlying antibiotic resistance at both bacterial-cell and community levels (biofilms). We also explore the SAR and the prospective clinical application of thiazole and its benzofused derivatives, which act as inhibitors of mechanisms underlying antibiotic resistance in the treatment of severe drug-resistant infections. In addition, we examined all bacterial targets involved in their antimicrobial activity reporting, when described, their spontaneous frequencies of resistance.
引用
收藏
页码:7923 / 7956
页数:34
相关论文
共 139 条
  • [11] Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp.
    Bao, BQ
    Sun, QS
    Yao, XS
    Hong, JK
    Lee, CO
    Sim, CJ
    Im, KS
    Jung, JH
    [J]. JOURNAL OF NATURAL PRODUCTS, 2005, 68 (05): : 711 - 715
  • [12] Recent progress in the discovery and development of DNA gyrase B inhibitors
    Barancokova, Michaela
    Kikelj, Danijel
    Ilas, Janez
    [J]. FUTURE MEDICINAL CHEMISTRY, 2018, 10 (10) : 1207 - 1227
  • [13] Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099)
    Basarab, Gregory S.
    Hill, Pamela J.
    Garner, C. Edwin
    Hull, Ken
    Green, Oluyinka
    Sherer, Brian A.
    Dangel, P. Brian
    Manchester, John I.
    Bist, Shanta
    Hauck, Sheila
    Zhou, Fei
    Uria-Nickelsen, Maria
    Illingworth, Ruth
    Alm, Richard
    Rooney, Mike
    Eakin, Ann E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (14) : 6060 - 6082
  • [14] A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
    Beno, Brett R.
    Yeung, Kap-Sun
    Bartberger, Michael D.
    Pennington, Lewis D.
    Meanwell, Nicholas A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4383 - 4438
  • [15] Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa
    Bernardes, Erik van Tilburg
    Charron-Mazenod, Laetitia
    Reading, David J.
    Reckseidler-Zenteno, Shauna L.
    Lewenza, Shawn
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [16] Bacterial adhesion at the single-cell level
    Berne, Cecile
    Ellison, Courtney K.
    Ducret, Adrien
    Brun, Yves V.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2018, 16 (10) : 616 - 627
  • [17] The Extracellular Matrix Component Psl Provides Fast-Acting Antibiotic Defense in Pseudomonas aeruginosa Biofilms
    Billings, Nicole
    Millan, Maria Ramirez
    Caldara, Marina
    Rusconi, Roberto
    Tarasova, Yekaterina
    Stocker, Roman
    Ribbeck, Katharina
    [J]. PLOS PATHOGENS, 2013, 9 (08)
  • [18] A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
    Bisacchi, Gregory S.
    Manchester, John I.
    [J]. ACS INFECTIOUS DISEASES, 2015, 1 (01): : 4 - 41
  • [19] Recent advances in bacterial topoisomerase inhibitors
    Bradbury, Barton J.
    Pucci, Michael J.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) : 574 - 581
  • [20] Discovery of the first antibacterial small molecule inhibitors of MurB
    Bronson, JJ
    DenBleyker, KL
    Falk, PJ
    Mate, RA
    Ho, HT
    Pucci, MJ
    Snyder, LB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 873 - 875